Dynamics of changes in the cellular composition of the focus of inflammation in secondary chronic inflammation with the introduction of mesenchymal stem cells
DOI:
https://doi.org/10.12775/JEHS.2020.10.01.033Keywords
secondary chronic inflammation, focus of inflammation, mesenchymal stem cellsAbstract
The study of the dynamics of the cellular composition of the inflammatory focus showed that an increase in the level of neutrophils, basophilic and eosinophilic leukocytes occurs during the observation period with a dominance in the central parts of the inflammation focus, aeosinophilia - similarly with a prevalence in the peripheral zones. This fact indicates the transition and the beginning of the proliferation phase. The results of our studies of the cellular composition of the inflammation focus in the dynamics of secondary chronic inflammation show that the use of MSCs leads to a decrease in the chronicity of the process. This proves the possibility of using MSCs to prevent chronic inflammation.
References
Steffens S, Winter C, Schloss MJ, Hidalgo A, Weber C, Soehnlein O. Circadian Control of Inflammatory Processes in Atherosclerosis and Its Complications. ArteriosclerThrombVasc Biol. 2017 Jun;37(6):1022-1028. doi: 10.1161/ATVBAHA.117.309374. Epub 2017 Apr 27. PMID: 28450299.
Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:321–334
Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E, Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood. 2005;105:2214–2219
Dazzi F, Marelli-Berg F.M. Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells. Eur J Immunol. 2008;38:1479–1482
Shi Y, Hu G, Su J, Li W, Chen Q, Shou P, Xu C, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010;20:510-518.
Leitner DR, Frühbeck G, Yumuk V, et al. 2017. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way. ObesFacts.10(5):483–492. doi:10.1159/000480525
Boloker, Gabrielle et al. Updated statistics of lung and bronchus cancer in United States. 2018. Journal of thoracic disease vol. 10,3 (2018): 1158-1161. doi:10.21037/jtd.2018.03.15.
Sitarz, Robert et al. 2018. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer management and research vol. 10 239-248. 7. doi:10.2147/CMAR.S149619.
Chen, W.-W., Zhang, X., & Huang, W.-J. 2016. Role of neuroinflammation in neurodegenerative diseases (Review). MolecularMedicineReports, 13(4), 3391–3396. doi:10.3892/mmr.2016.4948
Nathan, C., & Ding, A. 2010. Nonresolving Inflammation.Cell, 140(6), 871–882. doi:10.1016/j.cell.2010.02.029
Li W, Ren G, Huang Y, Su J, Han Y, Li J, Chen X, et al. Mesenchymal stem cells: HepatologyHepatology 26 a double-edged sword in regulating immune responses. Cell Death Differ 2012;19:1505-1513.
Zhang, Y., Cai, W., Huang, Q., Gu, Y., Shi, Y., Huang, J., Zhang, Y. (2013). Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells. Hepatology, 59(2), 671–682. doi:10.1002/hep.26670
Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505(7483):327–334. doi:10.1038/nature12984.
SusanneKern, HermannEichler, JohannesStoeve, HaraldKlüter, KarenBieback. 2012. Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue. StemCells 24(5):1294-1301.
Baldev R. Gulati, Rajesh Kumar, NiharikaMohanty, PawanKuma, Rajesh K. Somasundaram, Prem S. Yadav. 2013. Bone Morphogenetic Protein-12 Induces Tenogenic Differentiation of Mesenchymal Stem Cells Derived from Equine Amniotic Fluid. Cells Tissues Organs 2013;198:377–389 DOI: 10.1159/000358231
Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, Gorodetsky R. 2006. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. BoneMarrowTransplant. 2006 May;37(10):967-76. PMID:16670702DOI:10.1038/sj.bmt.1705358.
K. Uchida, K. Urabe, K. Naruse, M. Ujihira, K. Mabuchi, and M. Itoman. 2007. Comparison of the cytokine-induced migratory response between primary and subcultured populations of rat mesenchymal bone marrow cells. J OrthopSci 12:484–492 DOI 10.1007/s00776-007-1159-5.
Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. 2006. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. StemCells. 2006 Feb;24(2):462-71.DOI:10.1634/stemcells.2004-0331.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 150
Number of citations: 0
